Grafa News and Videos — Page 139

Fluence Energy (NASDAQ:FLNC) signed an agreement with Vattenfall to deliver the planned Brunsbüttel battery storage facility and provide long-term service support.

The Progressive Corporation (NYSE:PGR) reported third-quarter 2026 financial results, with earnings per share of $4.37 compared with analyst expectations of $4.42.

Sarepta Therapeutics (NASDAQ:SRPT) presented new preclinical findings from its SRP-1003 program at the 22nd Annual Meeting of the Oligonucleotide Therapeutics Society (OTS).

Viking Therapeutics (NASDAQ:VKTX) announced the start of its SUNRISE Phase 3 clinical program for oral VK2735, an investigational therapy being developed for obesity management.

Alpha Compute (NASDAQ:ALP) announced that it entered into a binding GPU compute services agreement on October 9, 2026, for its first contracted U.S. GPU cluster.

Parabilis Medicines (NASDAQ:PBLS) announced the initiation of a new dose-ranging cohort for zolucatetide in adults with familial adenomatous polyposis, a hereditary condition associated with the development of precancerous polyps.

Takeda Pharmaceutical (NYSE:TAK) presented new data from the pivotal Phase 2/3 IgGNITE clinical trial (TAK-881-3001) evaluating TAK-881 Immune Globulin Subcutaneous (Human), 20% Solution combined with recombinant human hyaluronidase.

Entrada Therapeutics (NASDAQ:TRDA) announced that an independent monitoring committee has recommended initiating Cohort 3 of its Phase 1/2 ELEVATE-44-201 clinical study.

Fusion Fuel (NASDAQ:HTOO) reported first-half 2026 financial results and provided its outlook for the remainder of the year.

Morgan Stanley (NYSE:MS) reported third-quarter 2026 financial results, beating analyst expectations on both revenue and earnings.